NPI: 1235708496 · WINDERMERE, FL 34786 · Pediatrics Physician · NPI assigned 06/22/2021
Authorized official BRIDGES, ROBERT controls 18+ related entities in our dataset. Read more
| Authorized Official | BRIDGES, ROBERT (EVP, OPERATIONS) |
| Parent Organization | CHILDREN'S HEALTH ALLIANCE, LLC |
| NPI Enumeration Date | 06/22/2021 |
Other providers sharing the same authorized official: BRIDGES, ROBERT
| Year | Claims | Total Paid |
|---|---|---|
| 2021 | 1,272 | $68K |
| 2022 | 2,461 | $158K |
| 2023 | 2,851 | $148K |
| 2024 | 1,345 | $78K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3,100 | 2,887 | $215K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 598 | 558 | $61K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 485 | 444 | $50K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 960 | 868 | $40K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 390 | 356 | $35K |
| 90461 | 363 | 307 | $11K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 95 | 92 | $11K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 109 | 96 | $9K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 61 | 60 | $6K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 39 | 39 | $5K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 352 | 330 | $5K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 27 | 26 | $2K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 28 | 27 | $750.76 |
| 0071A | 18 | 16 | $629.83 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 27 | 27 | $428.34 |
| 99173 | 147 | 142 | $420.00 | |
| 85018 | 172 | 171 | $363.88 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 45 | 40 | $225.22 |
| 80061 | Lipid panel | 13 | 13 | $203.78 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 14 | 14 | $132.00 |
| 99177 | 71 | 61 | $126.00 | |
| 36416 | 219 | 215 | $114.00 | |
| 90686 | 354 | 346 | $41.00 | |
| 90674 | 33 | 32 | $31.63 | |
| 91307 | 31 | 21 | $0.07 | |
| 94760 | 61 | 59 | $0.00 | |
| 92551 | 78 | 60 | $0.00 | |
| 90670 | 27 | 27 | $0.00 | |
| 90734 | 12 | 12 | $0.00 |